Related Experiment Videos

[Light therapy of newborns with hyperbilirubinemia]

J Moan1

  • 1Institutt for Kreftforskning, Det Norske Radiumhospital, Oslo.

Insights

Phototherapy effectively treats newborn jaundice by converting bilirubin into water-soluble products. The most crucial reaction involves irreversible Z-lumirubin formation, a safe and efficient treatment for neonatal hyperbilirubinemia.

Area of Science:

  • Biochemistry
  • Photochemistry
  • Neonatology

Context:

  • Neonatal jaundice, caused by bilirubin accumulation, affects a significant fraction of newborns.
  • High bilirubin levels pose a risk of irreversible brain damage (kernicterus).
  • Phototherapy is a common treatment for neonatal jaundice, used in 5-10% of Norwegian newborns.

Purpose:

  • To elucidate the photochemical reactions underlying phototherapy for neonatal jaundice.
  • To identify the key reactions responsible for bilirubin degradation and excretion.

Summary:

  • Phototherapy utilizes light to induce bilirubin breakdown through photooxidation and isomerization.
  • Key reactions include reversible isomer formation and irreversible Z-lumirubin production.
  • Z-lumirubin formation, an irreversible process, is considered the primary therapeutic mechanism, with its efficiency increasing with longer wavelengths.

Impact:

  • Understanding these photochemical pathways optimizes phototherapy efficacy and safety.
  • This knowledge contributes to managing hyperbilirubinemia and preventing kernicterus in newborns.
  • Phototherapy's transient side effects underscore its favorable safety profile in neonatal care.

Related Concept Videos